drugset / Trial / NCT02080767

Tecovirimat (ST-246) Treatment for Orthopox Virus Exposure

NCT02080767

Summary

The purpose of this clinical protocol is to treat individuals with Tecovirimat after exposure to orthopox viruses.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Tecovirimat Small molecule 600 mg Oral

Indications